- Vasculitis Drug Market Analysis, Market Size, Competitive Strategies, Forecasts to 2025 and Key Vendors: Merck, Bayer, Farmalider, Hainan Pharmaceutical FactoryMore – Gadget247News
- Inflarx (IFRX) Given New $64.00 Price Target at BMO Capital Markets – Finance Daily
- Zacks Investment Research Downgrades Inflarx (IFRX) to Hold – Finance Daily
- Intrasaccular Device Effective, Safe for Difficult Aneurysms – Medscape
- Trinity Researchers Secure €4m for Project Linking Data With Autoimmune Diseases – The University Times
- Biogen (NASDAQ:BIIB) had its Hold rating reiterated by JPMorgan Chase & Co. – Market Exclusive
- Vasculitis Treatment Market Entry Strategies, Counter measures of Economic Impact Channels to 2026 – Forex Tribune
- Vasculitis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 – Veteran’s Vista
- Global Vasculitis Drug Market Analysis 2019 : Merck, Bayer, Farmalider, Hainan Pharmaceutical Factory – Market Research Gazette
- Global Anca Vasculitis Drug Market: Key companies Profile, their market Share and other important parameters – Premier Herald
- Stelara: A New Option in Behcet’s? | Medpage Today – MedPage Today
- Is Buying 52-Week Stock Like InflaRx NV (IFRX) a Winning Strategy? – Invest Tribune
- CX deem paclitaxel not dangerous, but establishing the “truth takes time” – Vascular News
- What the Cat Dragged In? – Medscape
- Global Vasculitis Drug Market Insights 2019 – Merck, Bayer, Farmalider, Hainan Pharmaceutical Factory – Asiancrunch
Participate in Research
The Vasculitis Foundation's updated website design was generously funded with a grant by Genentech.
